A novel series of benzimidazole-sulfonamide hybrids (6a-g) was designed, synthesized, and their structures were characterized by 1 H NMR and 13 C NMR spectral data. Further, all compounds were evaluated for their antibacterial effects. The synthesized benzimidazole-sulfonamide hybrid (6d) showed the highest antibacterial activity against Staphylococcus aureus, Staphylococcus epidermis, Escherichia coli, and Klebsiella pneumonia. Different gel formulations for 6d were prepared and physically investigated. After in vivo evaluation for wound healing, the 6d gel formulation delayed the wound healing in animal model. But interestingly, a combination of 6d and Lucilia cuprina maggots' excretion/secretion showed remarkable enhancement in wound healing compared with 6d only. This combination opens up promising prospects for wound healing formulations.